Anavex Life Sciences Corporation (AVXL)’s financial ratios: A comprehensive overview

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.7 million shares were traded. AVXL stock price reached its highest trading level at $6.15 during the session, while it also had its lowest trading level at $5.71.

Ratios:

We take a closer look at AVXL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.12 and its Current Ratio is at 15.12. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.

On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.

On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 14 ’24 when Donhauser Peter D.O. bought 2,835 shares for $3.64 per share. The transaction valued at 10,319 led to the insider holds 5,000 shares of the business.

Thomas Steffen bought 5,000 shares of AVXL for $22,600 on May 15 ’24. The Director now owns 5,000 shares after completing the transaction at $4.52 per share. On Mar 28 ’24, another insider, MISSLING CHRISTOPHER U, who serves as the President and CEO of the company, sold 73,380 shares for $5.11 each. As a result, the insider received 374,972 and left with 1,250,210 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 493459968 and an Enterprise Value of 354074176.

Stock Price History:

The Beta on a monthly basis for AVXL is 0.67, which has changed by -0.30012006 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $10.45, while it has fallen to a 52-week low of $3.25. The 50-Day Moving Average of the stock is 40.34%, while the 200-Day Moving Average is calculated to be 6.16%.

Shares Statistics:

According to the various share statistics, AVXL traded on average about 1.17M shares per day over the past 3-months and 921890 shares per day over the past 10 days. A total of 82.07M shares are outstanding, with a floating share count of 82.05M. Insiders hold about 3.06% of the company’s shares, while institutions hold 37.78% stake in the company. Shares short for AVXL as of 1719532800 were 17825737 with a Short Ratio of 15.20, compared to 1717113600 on 21816277. Therefore, it implies a Short% of Shares Outstanding of 17825737 and a Short% of Float of 21.73.

Most Popular